We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$225B
1-Year Est. Return
49.49%
This Fund
S&P 500
This Quarter
Est. Return
+5.49%
1 Year Est. Return
+49.49%
3 Year Est. Return
+172.58%
5 Year Est. Return
+223.9%
10 Year Est. Return
+876%
AUM
$17.5B
AUM Growth
-$1.1B
(-5.9%)
Cap. Flow
-$1.74B
Cap. Flow
% of AUM
-9.95%
Top 10 Holdings %
Top 10 Hldgs %
16.94%
Holding
1,448
New
484
Increased
421
Reduced
286
Closed
239
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$277M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$266M |
| 3 |
Comcast
CMCSA
|
+$205M |
| 4 |
Bank of America
BAC
|
+$181M |
| 5 |
SHPG
Shire pic
SHPG
|
+$147M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
Philip Morris
PM
|
+$366M |
| 3 |
WisdomTree India Earnings Fund ETF
EPI
|
+$267M |
| 4 |
EOG Resources
EOG
|
+$265M |
| 5 |
Johnson & Johnson
JNJ
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.04% |
| 2 | Technology | 21.11% |
| 3 | Financials | 17.97% |
| 4 | Industrials | 10.54% |
| 5 | Consumer Discretionary | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$42.4B
| $394M | 2.25% |
6,853,633
+4,781,313
| +231% | +$266M |
|
2
Canadian National Railway
CNI
$74.6B
| $330M | 1.88% |
4,778,134
+1,992,294
| +72% | +$136M |
|
|
3
Citigroup
C
$231B
| $325M | 1.86% |
6,015,290
+5,224,742
| +661% | +$277M |
|
4
AstraZeneca
AZN
$252B
| $320M | 1.83% |
4,546,015
+163,002
| +4% | +$11.7M |
|
5
Nokia
NOK
$56.2B
| $283M | 1.62% |
36,048,991
-451,684
| -1% | -$3.65M |
|
6
HCA Healthcare
HCA
$87.7B
| $280M | 1.6% |
3,809,790
+728,598
| +24% | +$51.2M |
|
7
Qualcomm
QCOM
$180B
| $276M | 1.57% |
3,709,647
-1,530,301
| -29% | -$112M |
|
|
SHPG
8
DELISTED
Shire pic
SHPG
| $273M | 1.56% |
1,284,386
+694,056
| +118% | +$147M |
|
|
NVO
9
Novo Nordisk
NVO
$206B
| $252M | 1.44% |
11,905,700
+3,852,238
| +48% | +$86M |
|
10
TSMC
TSM
$2.22T
| $233M | 1.33% |
10,427,070
-4,365,651
| -30% | -$95.1M |
|
|
11
Comcast
CMCSA
$94B
| $222M | 1.27% |
7,640,258
+7,479,530
| +4,654% | +$205M |
|
12
Micron Technology
MU
$1.15T
| $212M | 1.21% |
6,066,091
+1,294,099
| +27% | +$42.8M |
|
13
Gilead Sciences
GILD
$187B
| $212M | 1.21% |
2,247,420
+107,192
| +5% | +$11.1M |
|
14
HP
HPQ
$29.4B
| $205M | 1.17% |
11,267,887
-2,924,844
| -21% | -$49M |
|
15
Union Pacific
UNP
$172B
| $200M | 1.14% |
1,680,148
+856,392
| +104% | +$98.3M |
|
|
TWC
16
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $192M | 1.1% |
1,262,908
+912,181
| +260% | +$132M |
|
|
17
Bank of America
BAC
$438B
| $189M | 1.08% |
+10,575,571
| New | +$181M |
|
18
UnitedHealth
UNH
$356B
| $185M | 1.06% |
1,831,960
-332,223
| -15% | -$31.5M |
|
19
American International
AIG
$39.8B
| $171M | 0.98% |
3,060,988
-139,381
| -4% | -$7.48M |
|
20
Canadian Pacific Kansas City
CP
$80.5B
| $167M | 0.95% |
4,317,600
+2,366,875
| +121% | +$93.7M |
|
21
Prudential Financial
PRU
$42.1B
| $150M | 0.86% |
1,656,402
-130,205
| -7% | -$11.2M |
|
22
Sanofi
SNY
$106B
| $139M | 0.79% |
3,041,605
+901,643
| +42% | +$43.7M |
|
23
Novartis
NVS
$304B
| $137M | 0.78% |
1,644,677
-1,283,978
| -44% | -$106M |
|
24
Ericsson
ERIC
$33B
| $136M | 0.78% |
11,266,732
+7,690,064
| +215% | +$92.6M |
|
25
HDFC Bank
HDB
$119B
| $135M | 0.77% |
10,634,704
-3,302,840
| -24% | -$41.7M |
|
Similar funds
JT
Arrowstreet Capital's Q4 2014 Portfolio in Review
As of Q4 2014, Arrowstreet Capital held 1,448 positions worth $17.5B, down 5.9% from $18.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Arrowstreet Capital withdrew a net $1.74B in Q4 2014, closing 239 positions and reducing 286 holdings. Its most notable exit was Apple, an estimated $762M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Technology and Financials.
Against the trend, Arrowstreet Capital opened a new position in Bank of America worth $189M.
- Arrowstreet Capital's largest Q4 2014 buy was Bank of America: 10,575,571 shares worth $189M.
- Arrowstreet Capital added most to Citigroup in Q4 2014, an estimated $277M increase.
- Arrowstreet Capital's biggest Q4 2014 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited Apple in Q4 2014, selling an estimated $762M.
- Arrowstreet Capital's ten largest holdings make up 17% of its $17.5B portfolio in Q4 2014.
- Arrowstreet Capital opened 484 new positions and closed 239 in Q4 2014.
- Arrowstreet Capital's portfolio value fell 5.9% quarter-over-quarter to $17.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2014, filed 13 Feb 2015.